DSHEA Weekly Digest – July 21, 2026
DSHEA Weekly Digest Weekly Digest July 21, 2026 Volume 4, Issue 3 What’s Inside This Week The most consequential challenge to DSHEA in years arrived
July 21, 2026
Our Media & Newsroom serves as a vital resource, offering insights and updates that keep our community informed. Explore key developments, important announcements, and resources that elevate our mission.
Welcome to the official media hub of the DSHEA Preservation Alliance. Here, journalists, researchers, and stakeholders can access reliable information, timely updates, and expert perspectives on the policies, challenges, and successes shaping the future of dietary supplement regulation. Whether you’re covering legal developments, tracking FDA activity, or exploring DSHEA’s impact on public health and innovation, our newsroom offers curated resources to support your work. Browse our press releases, statements, and recent headlines—or reach out directly for customized support. We’re here to ensure clarity, credibility, and context in every story.
DSHEA Weekly Digest Weekly Digest July 21, 2026 Volume 4, Issue 3 What’s Inside This Week The most consequential challenge to DSHEA in years arrived
DSHEA Weekly Digest – July 7, 2026 Weekly Digest July 7, 2026 Volume 4, Issue 1 What’s Inside This Week The week’s dominant story landed
DSHEA Weekly Digest – June 30, 2026 Weekly Digest June 30, 2026 Volume 3, Issue 5 What’s Inside This Week State enforcement took center stage
DSHEA Weekly Digest – June 16, 2026 Weekly Digest June 16, 2026 Volume 3, Issue 3 What’s Inside This Week A widening Salmonella outbreak tied
DSHEA Weekly Digest – June 16, 2026 Weekly Digest June 16, 2026 Volume 2, Issue 6 What’s Inside This Week CRN’s Day on the Hill
DSHEA Weekly Digest Weekly Digest June 9, 2026 Volume 3, Issue 2 What’s Inside This Week Enforcement and accountability dominated the past week, led by
Newsletter
The Natural Products Association (NPA) filed a lawsuit challenging the FDA’s determination that NMN is excluded from the definition of a dietary supplement due to its prior investigation as a drug. The NPA argues that the FDA’s retroactive application of the law is unlawful and harms the dietary supplement industry.
...Press Release
The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN) responded, expressing concern that this decision stifles innovation and disregards consumer interests.
...For all media requests or press inquiries related to the DSHEA or the DSHEA Preservation Alliance, please get in touch with us at info@dshea.org. We’re happy to assist journalists, researchers, and media professionals with timely information, expert insights, and background materials.
Subscribe to receive the latest updates on DSHEA enforcement, regulatory developments, research insights, and advocacy efforts—curated for policymakers, health professionals, industry leaders, and researchers.